Bionano genomics newsBionano Genomics Inc (NASDAQ: BNGO) has dropped $0.06 (2.59%) and is currently sitting at $2.27, as of 11:50:59 est on April 8. 1,809,626 shares have been traded today. TheBionano Genomics (NASDAQ:BNGO) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts estimate that ...Find the latest Bionano Genomics, Inc. (BNGO) stock quote, history, news and other vital information to help you with your stock trading and investing.Complete Bionano Genomics Inc. stock information by Barron's. View real-time BNGO stock price and news, along with industry-best analysis.BioNano Genomics Inc (BNGO) Down 2.27% in Premarket Trading. BioNano Genomics Inc ( BNGO) is down -2.27%% today. BNGO has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on BNGO! BNGO stock closed at $2.20 and is down -$0.05 during pre-market trading. Pre-market tends to be more volatile due to ...r/News_Finance. Fresh and trending news about Finance industry, business, employment, product, technology… and top companies in Finance industry, posted by news bot power by AI. Welcome to join and share your ideas and opinions. 570. Members.Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company's mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software.ACMG Foundation Receives Gift from Bionano Genomics, Inc. For Laboratory Genetics and Genomics Fellowships Three-Year Commitment Will Fund Training of Two PhD Students Each Year Through 2024-2025Bionano Genomics news and BNGO price. Free real-time prices, trades, and chat.Apr 11, 2022 · BioNano Genomics Inc (BNGO) Down 2.27% in Premarket Trading. BioNano Genomics Inc ( BNGO) is down -2.27%% today. BNGO has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on BNGO! BNGO stock closed at $2.20 and is down -$0.05 during pre-market trading. Pre-market tends to be more volatile due to ... Apr 08, 2022 · Bionano Genomics Inc (NASDAQ: BNGO) has dropped $0.06 (2.59%) and is currently sitting at $2.27, as of 11:50:59 est on April 8. 1,809,626 shares have been traded today. The Bionano Genomics Stock Forecast, Price & News $2.40 0.00 (0.00%) (As of 03/23/2022 12:00 AM ET) Today's Range $2.32 $2.49 50-Day Range $1.66 $2.55 52-Week Range $1.62 $9.12 Volume 5.23 million shs Average Volume 8.38 million shs Market Capitalization $695.07 million P/E Ratio N/A Dividend Yield N/A Beta 1.91 Profile Analyst Ratings ChartSAN DIEGO, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), provider of optical genome mapping (OGM) solutions on the Saphyr ® system and the leading software for genomic data ...Thinking about buying stock in BioNano Genomics, Ocugen Inc, Biolase, Gevo, or FuelCell Energy? News provided by. InvestorsObserver Dec 29, 2020, 11:00 ET. Share this article.BioNano Genomics Inc is lower by Monday morning, with the stock decreasing -5.58% in pre-market trading to 2.03.BNGO's short-term technical score of 7 indicates that the stock has traded less bullishly over the last month than 93% of stocks on the market.Apr 11, 2022 · Monday, April 11, 2022 08:21 AM | InvestorsObserver Analysts BioNano Genomics Inc ( BNGO) is down -2.27%% today. BNGO has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on BNGO! See Full BNGO Report BNGO stock closed at $2.20 and is down -$0.05 during pre-market trading. Real time Bionano Genomics, Inc (BNGO) stock price quote, stock graph, news & analysis.Bionano Genomics has been unprofitable since 2017 and is having a cash burn problem. In 2021, free cash flow reported was a loss of $73.4 million compared to a loss of $38.3 million in 2020. Keep ...Bionano's (BNGO) profile has grown considerably over the past year, mostly due to the disruptive potential of its... Oct 14, 2021. Bionano Genomics to Acquire BioDiscovery for $100M; Shares Rise 4.9%. Shares of genome analysis company Bionano Genomics, Inc. (BNGO) jumped 4.9% on Tuesday and closed at $5.40 in...15 hours ago · Bionano Genomics ( NASDAQ:BNGO – Get Rating) last issued its quarterly earnings data on Tuesday, March 1st. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the Zacks’... BioNano Genomics has had quite a bit of exposure recently, as the journal Nature used BioNano's Saphyr genome imaging technology to create one of the largest and accurate sets of genome data in ...Bionano Genomics, Inc. Biotechnology San Diego, California 17,333 followers See genome variation like never before with Bionano Optical Genome Mapping (OGM).Bionano Genomics Inc (NASDAQ: BNGO) has dropped $0.06 (2.59%) and is currently sitting at $2.27, as of 11:50:59 est on April 8. 1,809,626 shares have been traded today. TheBionano Genomics, Inc. is a genomics company, which provides optical genome mapping (OGM) for genome analysis. The Company offers diagnostic services to physicians specializing in medical ...Apr 11, 2022 · Bionano Genomics has been unprofitable since 2017 and is having a cash burn problem. In 2021, free cash flow reported was a loss of $73.4 million compared to a loss of $38.3 million in 2020. Keep ... Bionano Genomics lost a lot of supporters in recent months and some never came to the rescue, but a lifeline has been thrown to BNGO stock.10 hours ago · Bionano Genomics has been unprofitable since 2017 and is having a cash burn problem. In 2021, free cash flow reported was a loss of $73.4 million compared to a loss of $38.3 million in 2020. Keep... Bionano Genomics News Headlines $2.40 0.00 (0.00%) (As of 03/23/2022 12:00 AM ET) Today's Range $2.32 $2.49 50-Day Range $1.66 $2.55 52-Week Range $1.62 $9.12 Volume 5.23 million shs Average Volume 8.38 million shs Market Capitalization $695.07 million P/E Ratio N/A Dividend Yield N/A Beta 1.91 Profile Analyst Ratings Chart CompetitorsThe stock price of BioNano Genomics Inc (NASDAQ: BNGO) is trading at over 11% as of 3:27 PM ET. This is why it happened. This appears to be a continuation of an announcement from last week when Bionano Genomics announced the publication of a method for using optical genome mapping (OGM) to identify structural variants (SVs) that drive cancer in ...Bionano Genomics has been unprofitable since 2017 and is having a cash burn problem. In 2021, free cash flow reported was a loss of $73.4 million compared to a loss of $38.3 million in 2020. Keep ...ACMG Foundation Receives Gift from Bionano Genomics, Inc. For Laboratory Genetics and Genomics Fellowships Three-Year Commitment Will Fund Training of Two PhD Students Each Year Through 2024-2025Bionano Genomics, Inc., a genome analysis company, provides tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing. Its Saphyr system is a research use only platform for ultra-sensitive and ultra-specific structural variation detection that enables scientists and clinicians to ...10 hours ago · Bionano Genomics has been unprofitable since 2017 and is having a cash burn problem. In 2021, free cash flow reported was a loss of $73.4 million compared to a loss of $38.3 million in 2020. Keep... Read news, commentary, analysis and events related to BIONANO GENOMICS INC (BNGO).The BioNano Genomics Inc. stock price fell by -3.23% on the last day (Friday, 8th Apr 2022) from $2.32 to $2.25. and has now fallen 5 days in a row.During the day the stock fluctuated 3.81% from a day low at $2.23 to a day high of $2.32.The price has been going up and down for this period, and there has been a -5.27% loss for the last 2 weeks.Bionano Genomics Announces First Publication Demonstrating OGM as an Alternative to Karyotyping for Product of Conception Sample Analysis. Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™, the leading software solution for visualization, interpretation and reporting of genomic data, announced the first ...Bionano Genomics, Inc. (BNGO) Gains But Lags Market: What You Should Know. by Zacks Equity Research Published on March 01,2021. Bionano Genomics, Inc. (BNGO) closed at $9.84 in the latest trading ...The stock price of BioNano Genomics Inc (NASDAQ: BNGO) is trading at over 11% as of 3:27 PM ET. This is why it happened. This appears to be a continuation of an announcement from last week when Bionano Genomics announced the publication of a method for using optical genome mapping (OGM) to identify structural variants (SVs) that drive cancer in ...Bionano Genomics has been unprofitable since 2017 and is having a cash burn problem. In 2021, free cash flow reported was a loss of $73.4 million compared to a loss of $38.3 million in 2020. Keep...Bionano Genomics expected to generate further upside at BTIG despite 1,000% gain SA News Wed, Jun. 16, 2021 9 Comments Sage cut to neutral at Citi on data from depression trial, Bionano is a new ...BioNano Genomics' founder and chief scientific officer is Han Cao, who was a co-inventor of the technology while working as a postdoctoral researcher at Princeton. The system takes advantage of nanoscale channels that are so narrow that they permit only one DNA molecule to travel through the channel at a time.Bionano Genomics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.Bionano Genomics . Connect to CRM . Save . Summary Financials People Technology Signals & News Similar Companies. Recent News & Activity. Edit Recent News & Activity Section. Number of Articles 63. Introducing the Crunchbase Chrome extension . Download Now . Stay Connected . Crunchbase News ;On eToro, you can buy $BNGO or other stocks and pay ZERO commission! Follow BioNano Genomics Inc share price and get more information. Terms apply.BioNano Genomics, Inc NASDAQ Updated Apr 8, 2022 11:51 PM. BNGO 2.20 0.12 (5.17%). Post-Market 0.00 (0.00%)Get today's Bionano Genomics stock news. We cover the latest Bionano Genomics headlines and breaking news impacting Bionano Genomics stock performance.Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in ...Bionano Genomics, Inc. Biotechnology San Diego, California 17,333 followers See genome variation like never before with Bionano Optical Genome Mapping (OGM).Bionano Genomics, Inc. (BNGO) Gains But Lags Market: What You Should Know. by Zacks Equity Research Published on March 01,2021. Bionano Genomics, Inc. (BNGO) closed at $9.84 in the latest trading ...Shareholders of Bionano Genomics have been diluted in the past year, with total shares outstanding growing by 6.4%. This is the base news for valuation analysis. But I am mentioning this for ...Shareholders of Bionano Genomics have been diluted in the past year, with total shares outstanding growing by 6.4%. This is the base news for valuation analysis. But I am mentioning this for ...Event Highlights: At the Bionano Genomics 2022 Symposium, you will hear from over 25 customers around the world who will showcase their findings and answers using OGM. Each day will feature customer presentations, a live panel with Q&A, as well as poster presentations by topic area.10 hours ago · Bionano Genomics has been unprofitable since 2017 and is having a cash burn problem. In 2021, free cash flow reported was a loss of $73.4 million compared to a loss of $38.3 million in 2020. Keep... Disappointingly, Bionano expects to generate just a measly $30 million in revenues this year. The genetic testing market is expected to grow at a healthy 10.1% from 2020 to 2027 to $21.2 billion....BioNano Genomics, Inc NASDAQ Updated Apr 8, 2022 11:51 PM. BNGO 2.20 0.12 (5.17%). Post-Market 0.00 (0.00%)Bionano Genomics, Inc. announced the launch of an integrated genomic scar analysis for homologous recombination deficiency (HRD) in the version 6.2 software release of NxClinical. This feature provides a comprehensive, consistent, and automated analysis of biomarkers from next-generation sequencing (NGS) and microarray data that can help ...On eToro, you can buy $BNGO or other stocks and pay ZERO commission! Follow BioNano Genomics Inc share price and get more information. Terms apply.I am neutral on Bionano Genomics (), as it has strong growth momentum, enjoys unanimous support from Wall Street analysts, and its average price target implies massive upside potential over the next twelve months.However, the company is a long way from becoming profitable and is highly speculative. Bionano Genomics invests in diagnostic technology to detect various types of cancers.Apr 11, 2022 · Bionano Genomics has been unprofitable since 2017 and is having a cash burn problem. In 2021, free cash flow reported was a loss of $73.4 million compared to a loss of $38.3 million in 2020. Keep ... 15 hours ago · Shares of NASDAQ:BNGO opened at $2.20 on Monday. The company has a quick ratio of 11.91, a current ratio of 12.47 and a debt-to-equity ratio of 0.01. Bionano Genomics, Inc. has a twelve month low ... The COVID-19 Genomics UK (COG-UK) Consortium, formed in March 2020, is at the center of this herculean effort. Although numbers are changing every week, as of mid-March, the United Kingdom had ...Bionano Genomics is a California-based biotechnology company that develops genome mapping and analytics tools for sectors such as pharma and healthcare. Bionano Genomics was founded in 2003. Bionano Genomics' headquarters is located in San Diego, Cali...The stock price of BioNano Genomics Inc (NASDAQ: BNGO) is trading at over 11% as of 3:27 PM ET. This is why it happened. This appears to be a continuation of an announcement from last week when Bionano Genomics announced the publication of a method for using optical genome mapping (OGM) to identify structural variants (SVs) that drive cancer in ...News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here. Bionano Genomics, Inc. (Nasdaq: BNGO), ...Event Highlights: At the Bionano Genomics 2022 Symposium, you will hear from over 25 customers around the world who will showcase their findings and answers using OGM. Each day will feature customer presentations, a live panel with Q&A, as well as poster presentations by topic area.Bionano Genomics Stock Forecast, Price & News $2.40 0.00 (0.00%) (As of 03/23/2022 12:00 AM ET) Today's Range $2.32 $2.49 50-Day Range $1.66 $2.55 52-Week Range $1.62 $9.12 Volume 5.23 million shs Average Volume 8.38 million shs Market Capitalization $695.07 million P/E Ratio N/A Dividend Yield N/A Beta 1.91 Profile Analyst Ratings ChartThe stock price of BioNano Genomics Inc (NASDAQ: BNGO) is trading at over 11% as of 3:27 PM ET. This is why it happened. This appears to be a continuation of an announcement from last week when Bionano Genomics announced the publication of a method for using optical genome mapping (OGM) to identify structural variants (SVs) that drive cancer in ...Disappointingly, Bionano expects to generate just a measly $30 million in revenues this year. The genetic testing market is expected to grow at a healthy 10.1% from 2020 to 2027 to $21.2 billion....From a financial standpoint, Bionano Genomics is on solid ground. Also, the company is ready and able to address rare diseases with its OGM technology. This is great news for the medical community ...Bionano Genomics . Connect to CRM . Save . Summary Financials People Technology Signals & News Similar Companies. Recent News & Activity. Edit Recent News & Activity Section. Number of Articles 63. Introducing the Crunchbase Chrome extension . Download Now . Stay Connected . Crunchbase News ;Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform ...BioNano Genomics Inc (BNGO) Down 2.27% in Premarket Trading. BioNano Genomics Inc ( BNGO) is down -2.27%% today. BNGO has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on BNGO! BNGO stock closed at $2.20 and is down -$0.05 during pre-market trading. Pre-market tends to be more volatile due to ...Bionano Genomics, Inc. (NASDAQ:BNGO - Get Rating) - Equities research analysts at Oppenheimer cut their FY2022 earnings per share (EPS) estimates for Bionano Genomics in a report released on ...Get Bionano Genomics Inc (BNGO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Bionano Genomics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.Apr 11, 2022 · Bionano Genomics has been unprofitable since 2017 and is having a cash burn problem. In 2021, free cash flow reported was a loss of $73.4 million compared to a loss of $38.3 million in 2020. Keep ... The latest price target for Bionano Genomics ( NASDAQ: BNGO) was reported by BTIG on June 16, 2021. The analyst firm set a price target for 10.00 expecting BNGO to rise to within 12 months (a ...Bionano Genomics Inc (NASDAQ: BNGO) has dropped $0.06 (2.59%) and is currently sitting at $2.27, as of 11:50:59 est on April 8. 1,809,626 shares have been traded today. TheIn other Bionano Genomics stock news, in late November the company's CEO, Erik Holmer, bought $20,116-worth of the company's shares. Insider purchase of a company's stock is generally seen as a positive sign in the financial world.Read news, commentary, analysis and events related to BIONANO GENOMICS INC (BNGO).Bionano's (BNGO) profile has grown considerably over the past year, mostly due to the disruptive potential of its... Oct 14, 2021. Bionano Genomics to Acquire BioDiscovery for $100M; Shares Rise 4.9%. Shares of genome analysis company Bionano Genomics, Inc. (BNGO) jumped 4.9% on Tuesday and closed at $5.40 in...Find the latest Bionano Genomics, Inc. (BNGO) stock quote, history, news and other vital information to help you with your stock trading and investing.Since Bionano Genomics has shed US$87m from its value in the past 7 days, let's see if the longer term decline has been driven by the business' economics. View our latest analysis for Bionano Genomics . Because Bionano Genomics made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at ...Apr 08, 2022 · Bionano Genomics Inc (NASDAQ: BNGO) has dropped $0.06 (2.59%) and is currently sitting at $2.27, as of 11:50:59 est on April 8. 1,809,626 shares have been traded today. The SAN DIEGO, March 01, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr ® system and provider of N x Clincial™, a leading software solution for visualization, interpretation and reporting of genomic data, today reported financial results for the fourth quarter and ...BioNano Genomics has had quite a bit of exposure recently, as the journal Nature used BioNano's Saphyr genome imaging technology to create one of the largest and accurate sets of genome data in ...Bionano Genomics (BNGO) $ 2.42-0.17 (-6.76%) ... The good news is that it isn't too late for Cincinnati to learn from Seattle's mistakes and make the changes anyway. If the city council in ...Apr 11, 2022 · Bionano Genomics has been unprofitable since 2017 and is having a cash burn problem. In 2021, free cash flow reported was a loss of $73.4 million compared to a loss of $38.3 million in 2020. Keep ... Bionano Genomics, Inc. (NASDAQ:BNGO - Get Rating) - Equities research analysts at Oppenheimer cut their FY2022 earnings per share (EPS) estimates for Bionano Genomics in a report released on ...Get the latest Bionano Genomics, Inc. (BNGO) stock news and headlines to help you in your trading and investment decisions.News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here. Bionano Genomics, Inc. (Nasdaq: BNGO), ...Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in ...Bionano Genomics Stock Forecast, Price & News $2.40 0.00 (0.00%) (As of 03/23/2022 12:00 AM ET) Today's Range $2.32 $2.49 50-Day Range $1.66 $2.55 52-Week Range $1.62 $9.12 Volume 5.23 million shs Average Volume 8.38 million shs Market Capitalization $695.07 million P/E Ratio N/A Dividend Yield N/A Beta 1.91 Profile Analyst Ratings ChartWhen Bionano Genomics acquired Lineagen, Inc. in August, the genomic analysis company gained the final piece it needed to provide comprehensive structural variation detection for researchers and drug developers and a reimbursement pathway for clinicians who want to use its technology to replace cytogenetic tests to diagnose cancers and rare diseases.Apr 08, 2022 · Bionano Genomics Inc (NASDAQ: BNGO) has dropped $0.06 (2.59%) and is currently sitting at $2.27, as of 11:50:59 est on April 8. 1,809,626 shares have been traded today. The Webull offers kinds of BioNano Genomics Inc stock information, including NASDAQ:BNGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNGO stock news, and many more online research tools to help you make informed decisions.Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform ... - fd